Laurus Labs Ltd Share Price

Morepen Labs Completes Phase-1 Capacity Expansion

Close crossing last Month High Strategy.

Close crossing last Month High Strategy.

Innova Captab Board OKs ₹50 Cr Land Acquisition

A strong stock can outperform a weak market.

industry growth, earnings momentum, and investor confidence align together. Imagine the market is walking through a storm. The Nifty is under pressure, crude oil is rising, and sentiment is cautious. Yet, some companies continue climbing. **Sai Life Sciences** is one such example. On September 2, the Nifty 500 environment remained weak, while Sai Life Sciences touched a new lifetime high of ₹1,578 and gained about 8% across two sessions. Its trading volume also more than doubled. Sai Life Sciences operates in the **CRDMO** space—helping pharmaceutical and biotechnology companies with research, development and manufacturing. The larger opportunity comes from increasing global pharma outsourcing and demand for specialised therapies. The interesting part is that this is not an isolated industry story. Other **Nifty 500** healthcare names such as **Divi’s Laboratories, Laurus Labs, Gland Pharma and Neuland Laboratories** also provide useful examples for studying the CRDMO/pharma outsourcing theme. Business Standard has previously highlighted Sai Life Sciences, Laurus Labs and Divi’s Laboratories among stocks reaching fresh highs. 🔎 **What should a learner study?** • Revenue and profit growth • Order-book visibility • Industry CAGR and outsourcing trends • Operating margins • Valuation versus peers • Volume confirmation during price moves The lesson is simple: **when the market struggles, study the businesses that continue demonstrating fundamental strength—but never confuse relative strength with a guaranteed future return.**

Pre Market Analysis & Global Cues | 01 September, 2026

Global cues are slightly weak this morning. Tensions between the US and Iran have increased again, and there were strikes near the Strait of Hormuz. Because of this, crude oil has moved up. Brent is around $91, and this is not good for our market. Higher crude means pressure on inflation and the rupee. US markets closed slightly lower. Dow was down 0.7% and S&P fell 0.3%. At the same time, US 10Y yield has moved up to around 4.78%, which is on the higher side. Asian markets are mixed. Taiwan is slightly positive, while Japan, Korea and Hong Kong are in red. Because of this, Gift Nifty is indicating a 50–80 point gap-up, so the start may be slightly positive but volatile. Crude will be the key again today. It has moved from high-80s to around $91 in the last few sessions. If it stays high, pressure can come on the market. The rupee is near 95.1 and still weak. Also, India 10Y yield is around 6.95%, which is important for banking stocks. One positive from the domestic side: India’s Q1 GDP came at 7.8%, better than expectations. There will be strong stock-specific action today. Because of MSCI rebalancing, Laurus Labs and Adani Energy Solutions may see inflows, while SBI Cards, Astral and Balkrishna Industries may see some selling. In terms of news: E2E Networks is in focus after a ₹1,000 Cr AI deal. NCC and Ashoka Buildcon have order wins. Transformers & Rectifiers has also secured a nuclear-related order. On the weaker side: EPL may see pressure due to stake sale. Some FMCG stocks may remain under watch due to cost concerns. Sector-wise: ONGC and Oil India may stay strong with higher crude. Aviation, paints and tyre stocks may see pressure. Event to watch: Manufacturing PMI at 10:30 AM. Today's View: The start may be slightly positive, but overall tone is cautious. Crude and bond yields will decide the direction. If crude stays high, the market may struggle to hold gains. Expect a volatile and stock-specific session.

Laurus Labs: MSCI Inclusion Puts Pharma Stock in Focus

Laurus Labs Limited